These are the states with the highest risk for melanoma linked to UV rays
States with the highest rates of melanoma cases linked to ultraviolet radiation are spread across the United States on the East and West coasts, in Hawaii and in landlocked states, according to a study published Monday in the International Journal of Cancer. (Source: CNN.com - Health)
Source: CNN.com - Health - February 18, 2020 Category: Consumer Health News Source Type: news

Study identifies states with highest rates of melanoma due to ultraviolet radiation
(American Cancer Society) A new study finds a wide state-by-state variation in rates of melanoma caused by ultraviolet (UV) exposure with highest rates in several states on the East and West Coast including Hawaii, but also a few landlocked states, including Utah, Vermont, and Minnesota. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 17, 2020 Category: Cancer & Oncology Source Type: news

Scientists have identified protein involved in progression of lung cancer and melanoma
(Far Eastern Federal University) Scientists from Far Eastern Federal University (FEFU, Russia), University of Geneva (Switzerland), Minjiang University, and Fuzhou University (China) pointed out WDR74 protein playing an important role in lung cancer and melanoma primary tumors/metastases progression. During the research, the artificially gained WDR74 function brought about a high activity in cancer cells. However, when the function had been dropped cells failed to metastasize becoming more vulnerable to chemotherapy. Related articles are published in Cancer Letters and Oncogene. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 14, 2020 Category: Cancer & Oncology Source Type: news

FDG-PET/CT points to cervical cancer patient outcomes
Several indicators on pretreatment FDG-PET/CT scans can help predict overall...Read more on AuntMinnie.comRelated Reading: Biomarkers on PET, MRI show breast cancer risk FDG-PET/CT within a year of heart valve surgery looks safe FDG-PET/CT helps predict tuberculosis relapse 2 new PET tracers may best FDG in cancer imaging FDG-PET/CT aids in melanoma treatment assessment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 13, 2020 Category: Radiology Source Type: news

Circulating Tumor Cells May Predict Melanoma Relapse Circulating Tumor Cells May Predict Melanoma Relapse
In patients with stage III melanoma, levels of circulating tumor cells (CTCs) may predict relapse, potentially allowing for identification of individuals who could benefit from close surveillance or adjuvant therapy, researchers say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 12, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Circulating Tumor Cells Useful for Identification of Potential Melanoma Relapse
A recent study determined circulating tumor cells were associated with melanoma relapse, suggesting that this form of liquid biopsy could help identify patients who would benefit from adjuvant therapy. (Source: CancerNetwork)
Source: CancerNetwork - February 12, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news

HRT and the Risk of Melanoma in Post-menopausal Women HRT and the Risk of Melanoma in Post-menopausal Women
Studies have suggested that hormones may play a potential role in melanoma carcinogenesis. Is hormone replacement therapy associated with an increased risk of melanoma in post-menopausal women?Human Reproduction (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 11, 2020 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Smartphone Apps Not Accurate Enough to Detect All Melanomas
TUESDAY, Feb. 11, 2020 -- Current smartphone-based applications (apps) cannot detect all cases of melanoma or other skin cancers, according to a review published online Feb. 10 in The BMJ. Karoline Freeman, from the University of Birmingham in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 11, 2020 Category: Pharmaceuticals Source Type: news

Updated Staging Manual Better Predicts Outcomes of Melanoma Updated Staging Manual Better Predicts Outcomes of Melanoma
The eighth edition of the American Joint Committee on Cancer staging manual (AJCC8) outperforms the previous AJCC7 in predicting relapse-free survival (RFS) and overall survival (OS) in patients with melanoma, researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 11, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Prebiotics help mice fight melanoma by activating anti-tumor immunity
(Sanford Burnham Prebys Medical Discovery Institute) Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that two prebiotics, mucin and inulin, slowed the growth of melanoma in mice by boosting the immune system's ability to fight cancer. The study, published today in Cell Reports, provides further evidence that gut microbes have a role in shaping the immune response to cancer, and supports efforts to target the gut microbiome to enhance the efficacy of cancer therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 11, 2020 Category: Cancer & Oncology Source Type: news

Smartphone Apps for Suspicious Skin Lesions Unreliable Smartphone Apps for Suspicious Skin Lesions Unreliable
Smartphone apps marketed to the general public for use on suspicious skin lesions are unreliable, as they may miss melanoma, concludes a review.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 11, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Research uncovers new path for melanoma detection and treatment
(Edith Cowan University) A new way to spot melanoma cells circulating in the blood has the potential to significantly improve the monitoring of cancer patients and guide future treatment. Edith Cowan University's Melanoma Research Group, in collaboration with Harvard Medical School and clinicians at Western Australian hospitals, has pioneered a new technique to detect circulating tumour cells (CTCs) that could provide a new avenue for cancer diagnosis and therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 9, 2020 Category: Cancer & Oncology Source Type: news

Circulating Tumor Cells Predict Relapse in Stage III Melanoma
One or more CTCs independently linked to melanoma relapse at six and 54 months (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 8, 2020 Category: Cancer & Oncology Tags: Dermatology, Oncology, Pathology, Journal, Source Type: news

Circulating Tumor Cells Predict Relapse in Stage III Melanoma
FRIDAY, Feb. 7, 2020 -- For stage III melanoma patients, circulating tumor cells (CTCs) predict relapse, according to a study published online Feb. 3 in Clinical Cancer Research. Anthony Lucci, M.D., from the University of Texas MD Anderson Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 7, 2020 Category: Pharmaceuticals Source Type: news

Elios Therapeutics Presents New Phase IIb Data for Personalized Cancer Vaccine in High-Risk Melanoma Patients at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Vaccine Was Most Effective in Stage IV Melanoma; 73 Percent of Patients Who Completed the Primary Vaccine Series Were Disease-Free at 24 Months Results Reflect Synergistic Anti-Tumor Effect When Vaccine is Combined with Checkpoint Inhibitors AUSTIN, ... Biopharmaceuticals, Oncology Elios Therapeutics, cancer vaccine, melanoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 7, 2020 Category: Pharmaceuticals Source Type: news

Cold plasma patch could make immunotherapy more effective for treating melanoma, study finds
This study represents an important milestone for the field of plasma medicine,” said co-senior author Richard Wirz, professor of mechanical and aerospace engineering at UCLA Samueli. “It demonstrates that the microneedle patch can realize the plasma delivery while also working with the drug t o improve the effectiveness of cancer therapy.”“Plasma can generate reactive oxygen species and reactive nitrogen species, which are a group of chemical species that can destroy cancer cells,” said Guojun Chen, who is the co-first author of the study and a postdoctoral fellow in Gu’s laboratory.&ldq...
Source: UCLA Newsroom: Health Sciences - February 6, 2020 Category: Universities & Medical Training Source Type: news

After Cancer Took His Mother, James Allison Taught Our Immune Systems How to Fight It
There once was a boy in Alice, Texas, who saw things a little differently from everybody else. Influenced by his father, a “country” doctor, he was drawn to science instead of football and conducted biology experiments in his parents’ garage. When he was 10, someone gave him a harmonica, but he never took a lesson or learned to read music, so he wandered the woods mimicking what he’d heard on the radio. A year after that, his mother died following a long struggle with lymphoma. What he still remembers decades later are her last, bedridden days when he spent hours holding her hand, and the burns sing...
Source: TIME: Health - February 6, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Research Source Type: news

Combination Treatments May Improve Survival for Patients with Metastatic Uveal Melanoma
The authors indicated that prospective clinical trials investigating DTIC-based systemic chemotherapies and liver-directed treatments are necessary to validate their findings. (Source: CancerNetwork)
Source: CancerNetwork - February 6, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Do elevated mercury levels in the blood increase skin cancer risk?
(Wiley) Higher levels of mercury in the blood were linked with a higher prevalence of non-melanoma skin cancer, the most common human malignancy, in a study published in the British Journal of Dermatology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 5, 2020 Category: Cancer & Oncology Source Type: news

UArizona receives $6.9m grant to study prevention of non-melanoma skin cancer
(University of Arizona Health Sciences) Skin cancer is the most common malignancy worldwide, and one in three new cancers diagnosed is a form of skin cancer. In response, a team of researchers at the University of Arizona Cancer Center is developing new strategies to prevent and reduce the risk of squamous cell carcinoma, the second most-common form of non-melanoma skin cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 5, 2020 Category: Cancer & Oncology Source Type: news

Liquid biopsy is effective predictor of melanoma relapse
Assessment of circulating tumour cells at first clinic visit could help identify patients who need most aggressive therapy Related items fromOnMedica Cancer patients using complementary meds die sooner UK cancer survival improved, but lags behind similar nations Is crowdfunding for cancer patients paying for ‘quackery’? NHS must improve access to screening to save lives Pharmacists could offer high-dose statins direct to patients (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 4, 2020 Category: UK Health Source Type: news

Shift in treatment modalities associated with improved outcomes in uveal melanoma patients with live
(Thomas Jefferson University) New retrospective study indicates that the shift of treatment from systemic chemotherapies to liver-directed therapies provides survival benefits. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 3, 2020 Category: Cancer & Oncology Source Type: news

Cold plasma patch could make immunotherapy more effective for treating melanoma
(University of California - Los Angeles Health Sciences) An interdisciplinary team of researchers at the UCLA has developed a medicated patch that can deliver immune checkpoint inhibitors and cold plasma directly to tumors to help boost the immune response and kill cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 3, 2020 Category: Cancer & Oncology Source Type: news

Study demonstrates liquid biopsy as effective predictor of stage III melanoma relapse and treatment
(University of Texas M. D. Anderson Cancer Center) A study at The University of Texas MD Anderson Cancer Center showed that circulating tumor cells (CTCs), a form of liquid biopsy, was independently associated with melanoma relapse, suggesting CTC assessment may be useful in identifying patients at risk for relapse who could benefit from more aggressive therapy following primary treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 3, 2020 Category: Cancer & Oncology Source Type: news

Researchers identify possible new combination treatment for advanced melanoma
FINDINGSA study by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusion of anti-tumor immune cells, or T cells, may produce a stronger immune response that could help fight advanced melanoma.When tested in mice with melanoma tumors that were unlikely to stimulate an immune response, the approach increased the number of anti-tumor immune cells, and those immune cells lived longer and functioned better than the standard therapy, empowering the cells to destroy the tumor.BACKGROUNDAdoptive cell th...
Source: UCLA Newsroom: Health Sciences - January 31, 2020 Category: Universities & Medical Training Source Type: news

Researchers identify possible new combination treatment for advanced melanoma
(University of California - Los Angeles Health Sciences) Immunotherapy drug in combination with an infusion of anti-tumor immune cells may produce a stronger immune response that could help fight advanced melanoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 31, 2020 Category: Cancer & Oncology Source Type: news

ONCOS-102 Shows Promise in Combination Mesothelioma Treatment
ONCOS-102, a promising immunotherapy vaccine, is moving closer to becoming a part of future first-line treatment for mesothelioma. Early clinical trial results announced this week show safety and efficacy when the vaccine is used in combination with standard-of-care chemotherapy for patients with inoperable pleural mesothelioma. Targovax, a Scandinavian pharmaceutical company developing the drug, is moving forward with another study combining ONCOS-102 with a checkpoint inhibitor drug such as Keytruda (pembrolizumab) or Opdivo (nivolumab), along with chemotherapy. “We have seen enough data at this point to be going ...
Source: Asbestos and Mesothelioma News - January 27, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Doctors and immunologists implement a new approach for melanoma treatment
(Estonian Research Council) Worldwide, the incidence rates of skin cancer, like other types of cancer, is increasing. People in Europe and the Nordic countries are, compared to other areas of the world, at a higher risk of developing skin cancer due to their predominantly light and sun-sensitive skin type. The number of new cases of cancer in Estonia and Nordic countries has reached the same level as in sunny Australia, New Zealand and Florida. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 27, 2020 Category: International Medicine & Public Health Source Type: news

How Artificial Intelligence Helps Diagnose Skin Cancer
Artificial intelligence (AI) is ramping up how dermatologists diagnose skin conditions, even serious cancers like melanoma. (Source: WebMD Health)
Source: WebMD Health - January 24, 2020 Category: Consumer Health News Source Type: news

FDA: 7 Sunscreen Chemicals Enter Bloodstream After Use, But Don ’ t Abandon Sun Protection
(CNN) — After a single application, a total of seven chemicals commonly found in sunscreens can be absorbed into the bloodstream at levels that exceed safety thresholds, according to studies by the Center for Drug Evaluation and Research, an arm of the US Food and Drug Administration. “What is most alarming about these findings is that chemicals are absorbing into the body in significant amounts and the ingredients have not been fully tested for safety,” said David Andrews, a senior scientist for the Environmental Working Group, or EWG, a consumer organization which advocates for sunscreen safety. “...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 21, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Sunscreen Source Type: news

New Biomarkers Improve Stratification of Melanoma Patients New Biomarkers Improve Stratification of Melanoma Patients
Two new studies identify novel biomarkers that can be incorporated into clinical practice and may help identify patients with melanoma with improved survival.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 21, 2020 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Scientists study zebrafish in search of melanoma-fighting drugs
(Northern Arizona University) Northern Arizona University biologist Matt Salanga leads an 18-month project to find a combination of drugs to fight melanoma, the deadliest form of skin cancer (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 21, 2020 Category: International Medicine & Public Health Source Type: news

New technique predicts which melanoma patients are at risk for cancer recurrence, spread
(Brigham and Women's Hospital) Investigators from Brigham and Women's Hospital, in collaboration with international colleagues, present a new, quantitative technique that leverages DNA sequencing to make more sophisticated and accurate predictions about which primary melanomas are likely to recur and spread. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 20, 2020 Category: Cancer & Oncology Source Type: news

New Technique Predicts Which Melanoma Patients Are at Risk for Cancer Recurrence and Spread
Investigators from Brigham and Women ’s Hospital present a new, quantitative technique that leverages DNA sequencing to make more sophisticated and accurate predictions about which primary melanomas are likely to recur and spread. (Source: BWH News)
Source: BWH News - January 20, 2020 Category: Hospital Management Source Type: news

Lack of Self - Exams Hampers Early Melanoma Identification
Of those surveyed in rural communities, 43 percent intended to perform self - exam but did not follow through (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 17, 2020 Category: Cancer & Oncology Tags: Dermatology, Family Medicine, Internal Medicine, Oncology, Journal, Source Type: news

Lack of Self-Exams Hampers Early Melanoma Identification
FRIDAY, Jan. 17, 2020 -- The biggest obstacle to early detection and treatment of melanoma among residents of rural, frontier communities is a chronic lack of skin self-examination (SSE), according to a study recently published in Psychology, Health... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 17, 2020 Category: Pharmaceuticals Source Type: news

Man has mole removed after finding out he had skin cancer when app told him to visit doctor
Jason Sheridan, 31, from Liverpool, discovered he had melanoma after using the app, called SkinVision, which checks moles for potentially dangerous changes. (Source: the Mail online | Health)
Source: the Mail online | Health - January 17, 2020 Category: Consumer Health News Source Type: news

Satisfaction High With Mohs Surgery for Melanoma In Situ
Short - term, long - term patient satisfaction high with Mohs micrographic surgery for melanoma in situ (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 16, 2020 Category: Cancer & Oncology Tags: Dermatology, Oncology, Surgery, Journal, Source Type: news

Satisfaction High With Mohs Surgery for Melanoma In Situ
THURSDAY, Jan. 16, 2020 -- Patients are very satisfied with Mohs micrographic surgery (MMS) for melanoma in situ, according to a research letter recently published in Dermatologic Surgery. Daniel Condie, M.D., from the UT Southwestern Medical Center... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 16, 2020 Category: Pharmaceuticals Source Type: news

B cells linked to effective cancer immunotherapy
Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden. The study is published in Nature. (Source: World Pharma News)
Source: World Pharma News - January 16, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

B cells linked to effective cancer immunotherapy
(Lund University) Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumors contained specific clusters of B cells, according to new research from Lund University in Sweden. The study is published in Nature. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 16, 2020 Category: Cancer & Oncology Source Type: news

Body's natural signal carriers can help melanoma spread
(University of Eastern Finland) A new study from Finland sheds fresh light on how melanoma cells interact with other cells via extracellular vesicles they secrete. The researchers found that extracellular vesicles secreted by melanoma cells use the so-called hedgehog signalling pathway to intensify the malignant properties of the cells they are targeting. The discovery can help in the development of better treatment and diagnostics for melanoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 16, 2020 Category: Cancer & Oncology Source Type: news

Medical News Today: Aggressive melanoma: Circular RNA explains spread
New research in mice and cell cultures shows for the first time that a key circular RNA can block the spread of aggressive skin cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 15, 2020 Category: Consumer Health News Tags: Melanoma / Skin Cancer Source Type: news

B-cell enrichment predictive of immunotherapy response in melanoma, sarcoma and kidney cancer
(University of Texas M. D. Anderson Cancer Center) Multiple studies out in Nature indicate that a patient's response to immune checkpoint blockade may depend on B cells located in special structures within the tumor. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 15, 2020 Category: Cancer & Oncology Source Type: news

Skin cancer suppressor found by Bath scientists
(University of Bath) A promising route to develop new treatments for skin cancer has been identified by the UK's University of Bath scientists, who have found a molecule that suppresses melanoma tumour growth. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 14, 2020 Category: Cancer & Oncology Source Type: news

Entrepreneur who fought her own tumours has written a moving book to stop cancer ravaging your mind
Suki Thompson, 52, from Berkhamsted, Hertfordshire was diagnosed with breast cancer within a year of her divorce in 2008. She developed melanoma in 2013, 2016 and 2018. (Source: the Mail online | Health)
Source: the Mail online | Health - January 13, 2020 Category: Consumer Health News Source Type: news

Melanoma cells may develop new 'skin' to resist cancer treatments
In a study published Monday in the journal Cancer Cell, the authors from Queen Mary University of London describe how melanoma cells fight anti-cancer drugs by changing their internal skeleton, or cytoskeleton. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 13, 2020 Category: Consumer Health News Source Type: news

Research identifies new route for tackling drug resistance in skin cancer cells
(Queen Mary University of London) Researchers have found that melanoma cells fight anti-cancer drugs by changing their internal skeleton (cytoskeleton) -- opening up a new therapeutic route for combating skin and other cancers that develop resistance to treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 13, 2020 Category: Cancer & Oncology Source Type: news

Moffitt researchers identify molecular characteristics of leptomeningeal melanoma metastases
(H. Lee Moffitt Cancer Center& Research Institute) Very little information is known about the molecular development of leptomeningeal melanoma metastases (LMM), making it difficult to develop effective therapies. Researchers in Moffitt Cancer Center's Donald A. Adam Melanoma and Skin Cancer Center of Excellence and the Department of Neuro-Oncology sought to change this by performing an extensive analysis of the molecular characteristics of the cerebrospinal fluid of patients with LMM. Their findings were published in Clinical Cancer Research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 10, 2020 Category: Cancer & Oncology Source Type: news

Study finds 95 percent satisfaction rate with Mohs surgery
(UT Southwestern Medical Center) Patients who received Mohs surgery to treat the most serious form of skin cancer, melanoma, reported a 95 percent long-term satisfaction rate with their results, according to a new study by UT Southwestern Medical Center dermatologists. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 10, 2020 Category: International Medicine & Public Health Source Type: news